Celeste Marcos

458 total citations
11 papers, 41 citations indexed

About

Celeste Marcos is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Celeste Marcos has authored 11 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 2 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Celeste Marcos's work include Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Cystic Fibrosis Research Advances (3 papers) and Pneumonia and Respiratory Infections (2 papers). Celeste Marcos is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Cystic Fibrosis Research Advances (3 papers) and Pneumonia and Respiratory Infections (2 papers). Celeste Marcos collaborates with scholars based in Spain. Celeste Marcos's co-authors include Carolina Cisneros, Julio Ancochea, Enrique Zamora, Rosa Girón, Pedro Landete, Joan B. Soriano, José Marı́a Eiros Bouza, Elena García Castillo, Adrián Peláez and Claudia Valenzuela and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Sleep Medicine.

In The Last Decade

Celeste Marcos

9 papers receiving 39 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celeste Marcos Spain 4 27 22 8 6 3 11 41
Ricardo Tosca Spain 5 28 1.0× 26 1.2× 8 1.0× 2 0.3× 10 49
Soumendu Manna United Kingdom 2 20 0.7× 4 0.2× 17 2.1× 5 0.8× 4 1.3× 2 29
Hakim Rahmoune Algeria 3 18 0.7× 9 0.4× 3 0.4× 16 27
Mariana Meireles Portugal 3 11 0.4× 13 0.6× 3 0.5× 1 0.3× 6 26
Lorna Murray United Kingdom 2 32 1.2× 31 1.4× 2 0.3× 2 43
Gabriella Long United Kingdom 2 23 0.9× 13 0.6× 1 0.1× 3 0.5× 1 0.3× 4 26
Ashrafjit S. Chahal India 3 11 0.4× 9 0.4× 8 1.3× 5 14
Karolina Krassowska United Kingdom 2 27 1.0× 26 1.2× 2 37
Helen Jeffers United Kingdom 2 35 1.3× 27 1.2× 3 39
Johannes Gebauer Germany 2 6 0.2× 4 0.2× 2 0.3× 7 1.2× 5 1.7× 2 20

Countries citing papers authored by Celeste Marcos

Since Specialization
Citations

This map shows the geographic impact of Celeste Marcos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celeste Marcos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celeste Marcos more than expected).

Fields of papers citing papers by Celeste Marcos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celeste Marcos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celeste Marcos. The network helps show where Celeste Marcos may publish in the future.

Co-authorship network of co-authors of Celeste Marcos

This figure shows the co-authorship network connecting the top 25 collaborators of Celeste Marcos. A scholar is included among the top collaborators of Celeste Marcos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celeste Marcos. Celeste Marcos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Puente‐Maestu, Luís, José Luis Valera, Yolanda T. Garcia, et al.. (2025). Gestión de riesgos en la realización de pruebas de función pulmonar pospandemia. Open Respiratory Archives. 7(3). 100459–100459.
2.
Martínez‐Fleta, Pedro, Celeste Marcos, Daniel Jiménez‐Carretero, et al.. (2024). Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVID. Clinical Immunology. 264. 110267–110267. 1 indexed citations
3.
Marcos, Celeste, et al.. (2024). Mounier-Kuhn syndrome in poorly controlled asthma. Journal of Asthma. 61(10). 1351–1354. 1 indexed citations
4.
Soriano, Joan B., Adrián Peláez, Xavier Busquets, et al.. (2023). ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study. PLoS ONE. 18(6). e0286769–e0286769. 2 indexed citations
5.
Peláez, Adrián, Joan B. Soriano, Rosa Girón, et al.. (2022). Genitourinary tract symptoms in patients admitted with COVID-19: Exploring changes in frequency by determinants and pandemic waves. SHILAP Revista de lepidopterología. 5. 100572–100572. 3 indexed citations
6.
Cisneros, Carolina, José Marı́a Eiros Bouza, Celeste Marcos, et al.. (2022). Obstructive sleep apnea: The key for a better asthma control?. Sleep Medicine. 101. 135–137. 10 indexed citations
7.
Marcos, Celeste, et al.. (2022). What is the added value of FeNO as T2 biomarker?. SHILAP Revista de lepidopterología. 3. 957106–957106. 10 indexed citations
8.
Marcos, Celeste, et al.. (2022). Patología respiratoria. Clasificación y estrategia diagnóstica. Medicine - Programa de Formación Médica Continuada Acreditado. 13(63). 3701–3712.
9.
Marcos, Celeste, et al.. (2017). Experience with Aerosolized Imipenem in Patients with Cystic Fibrosis and Achromobacter xylosoxidans. Journal of Infectious Diseases and Therapy. 5(5). 2 indexed citations
10.
Marcos, Celeste, Rosa Girón, Elena García Castillo, et al.. (2015). Tobramycin inhalation powder (TOBI Podhaler®) for the treatment of lung infection in patients with cystic fibrosis. Expert Review of Anti-infective Therapy. 14(1). 9–17. 11 indexed citations
11.
Marcos, Celeste, et al.. (2015). Cystic Fibrosis and Piperacillin/Tazobactam: Adverse Reactions. Archivos de Bronconeumología. 51(12). 664–665. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026